Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US7169889B1 · kind B1 · utility
0Cited by
150References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2000 |
| Grant date | Jan 30, 2007 |
| Priority date | — |
| Expiry date | Jun 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to hydrolyzable drug-oligomer conjugates, pharmaceutical compositions comprising such conjugates, and to methods for making and using such conjugates and pharmaceutical compositions. For example, a conjugate of insulin, PEG, and oleic acid can be orally administered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.